Page last updated: 2024-08-21

levonorgestrel and Body Weight

levonorgestrel has been researched along with Body Weight in 92 studies

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-199027 (29.35)18.7374
1990's27 (29.35)18.2507
2000's15 (16.30)29.6817
2010's21 (22.83)24.3611
2020's2 (2.17)2.80

Authors

AuthorsStudies
Adeyanju, OA; Olatunji, LA1
Apter, D; Bitzer, J; Höchel, J; Hofmann, BM; Merz, M; Reinecke, I; Serrani, M1
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO1
Cartault, A; Pienkowski, C1
Kardos, L; Luczai, E; Magyar, G; Schváb, E1
Cleland, K; Smith, NK; Trussell, J; Wagner, B1
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Trussell, J1
Cleland, K; Wood, S1
Abitbol, JL; Gainer, E; Guillard, H; Kapp, N; Mathé, H; Scherrer, B; Ulmann, A1
Kohn, JE; Lopez, PM; Simons, HR1
Vogel, L1
Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD1
Gemzell-Danielsson, K; Kardos, L; von Hertzen, H1
Cholakian, D; Fader, AN; Gehrig, PA; Hacker, K; Tanner, EJ1
Jusko, WJ1
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Ramesh, S; Trussell, J1
Madden, T; Omvig, K; Peipert, JF; Silva Dos Santos, PN1
Kashanian, M; Shahpourian, F; Zare, O1
Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT1
Chen-Mok, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Trussell, J1
Hait, HI; Reape, KZ; Westhoff, CL1
Bahamondes, L; Bahamondes, MV; Dal'Ava, N; de Oliveira Santos, A; Monteiro, I1
Chen, B; Huang, Y; Xin, X; Yuan, P1
Berman, N; Clevenger, B; Garcia, R; Gonzalo, IT; Nelson, AL; Swerdloff, RS; Wang, C1
Ratnam, SS; Singh, K; Viegas, OA1
Gonzalez-ansorena, R; Rubio-lotvin, B; Ruiz-moreno, JA1
Lopez, G; Rodriguiz, A1
Defoort, P; Martens, G; Merchiers, E; Parewijck, W; Thiery, M; Van Kets, H1
Becker, KA; Emans, SJ; Feldman, HA; Goodman, E; Gordon, CM; Grace, E; Gundberg, CM; LeBoff, MS; Rosen, CJ1
Taneepanichskul, S; Tantbirojn, P1
Abraham, S; Luscombe, G; Soo, I1
Suthipongse, W; Taneepanichskul, S1
Shittu, O; Sule, S1
Guardianelli, F; Lello, S; Melis, GB; Paoletti, AM; Sorge, R; Vittori, G1
Balogun, OR1
Samsioe, G1
Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M1
Christie, T1
Haspels, AA1
Woutersz, TB1
Casado, ME; Croxatto, HB; Díaz, S; Durán, E; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM2
Deville, JL; Dubois, M; Gaspard, UJ1
Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U1
Hillesheim, HG; Hoffmann, H1
Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B1
Kühl, C; Mølsted-Pedersen, L; Skouby, SO1
Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG1
Noerpramana, NP1
Hales, HA; Hatasaka, HH; Jones, KP; Mainwaring, R; Peterson, CM; Poulson, AM; Stevenson, K1
Davis, P; Hendon, A; Kozlowski, KJ; Rickert, VI1
Berenson, AB; Wiemann, CM1
Harrison, FN; Laurent, S; Phemister, DA1
Bachmann, GA; Knuppel, RA; Owens, AG; Pasquale, SA1
Jiang, X; Li, H; Lin, D; Shen, Q; Zhang, Z1
Inayatullah, A; Rehan, N; Shamim, N1
Croxatto, HB1
Du, M; Gao, Y; Gu, S; He, X; Meng, F; Sivin, I; Wang, P; Wu, S; Ying, L; Zhang, L1
Anderson, NG; Grubb, GS; Moore, D1
Amatya, RN; Dunson, TR; Krueger, SL1
Alvarez, F; Bilhareus, P; Brache, V; Darney, P; Diaz, S; Klaisle, C; Koetsawang, S; Lacarra, M; LaGuardia, K; Lähteenmäki, P; Mishell, DR; Nash, H; Pavez, M; Piya-Anant, M; Ranta, S; Sivin, I; Stern, J; Viegas, OA; Wan, L1
Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR1
Chaudhary, I; Inayatullah, A; Rehan, N1
Chen, CH; Chow, LP; Du, MK; Zheng, HM1
Kübler, W; Nawroth, PP; Salbach, B; Salbach, PB; von Holst, Th1
Abdalla, K; Alvarez, F; Biswas, A; Brache, V; Campodonico, I; Darney, P; Diaz, S; Holma, P; Kiriwat, O; Mishell, DR; Pasquale, S; Pavez, M; Schechter, J; Sivin, I; Wan, L1
Archer, DF; Harrison, DD; Lemay, A; Roberts, J; Thiboutot, D; Washenik, K1
Alvarez, F; Anant, MP; Biswas, A; Brache, V; Darney, P; Diaz, S; Kiriwat, O; Klaisle, C; Mishell, DR; Pavez, M; Ranta, S; Schechter, J; Sivin, I; Wan, L1
Coney, P; DiGiovanna, JJ; Harrison, DD; Langley, RG; Washenik, K1
Georgiev, DB; Golbs, S; Goudev, A1
Bloch, B1
Dain, MP; Janaud, A; Rouffy, J; Upmalis, D1
Fakeye, O1
Ashwell, E; Ball, MJ; Gillmer, MD1
Christiansen, C; Haarbo, J; Leth-Espensen, P; Stender, S1
Eneroth, P; Jonsson, B; Landgren, BM1
Otubu, JA; Towobola, OA; Uguru, VE1
Andrade, AT; Cuadros, A; Dhall, GI; Ji, G; Khan, T; Koetsawang, S; Kononova, ES; Krishna, U; Rodriquez la Puenta, J; Wyss, R1
Apelo, R; Osteria, T; Ramos, R; Vilar, E1
Ratnam, SS; Singh, K; Singh, P; Viegas, OA2
Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP1
Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM1
Allonen, H; Andersson, K; Batar, I; Haukkamaa, M; Holma, P; Lampe, L; Luukkainen, T; Pyörälä, T; Terho, J; Toivonen, J1
de Castro, AM; de Castro, ML; Giovanini, ME; Gomes, FM; Koifman, S; Mota, LG; Oliveira, DP; Paes, SJ; Poyares, JA; Vianna, NF1
Nair, KM; Prasad, KV; Rao, BS; Sivakumar, B1
Cárdenas, H; Croxatto, HB; Díaz, S; Johansson, ED; Larsson, M; Pavez, M1
Chaudhury, N; Gupta, AN; Hazra, MN; Hingorani, V; Kochhar, M; Kodkany, BS; Logambal, A; Nanda, UK; Rai Choudhary, G; Raja Ram, P1
Abdullah, KA; Salem, HT; Shaaban, MM1
Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Peralta, O1

Reviews

8 review(s) available for levonorgestrel and Body Weight

ArticleYear
[Contraception for adolescent : CNGOF Contraception guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12

    Topics: Adolescent; Adolescent Health; Body Height; Body Mass Index; Body Weight; Calcification, Physiologic; Condoms; Contraception; Contraceptives, Oral, Hormonal; Female; France; Health Education; Humans; Levonorgestrel; Male; Papillomavirus Infections; Papillomavirus Vaccines; Pregnancy; Pregnancy, Unplanned; Sex Education; Sexually Transmitted Diseases

2018
Levonorgestrel emergency contraception and bodyweight.
    Current medical research and opinion, 2019, Volume: 35, Issue:7

    Topics: Body Weight; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Pregnancy Rate

2019
Progestin-only contraceptives: effects on weight.
    The Cochrane database of systematic reviews, 2013, Jul-02, Issue:7

    Topics: Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain

2013
Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials.
    Current medical research and opinion, 2015, Volume: 31, Issue:12

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Double-Blind Method; Female; Humans; Levonorgestrel; Middle Aged; Overweight; Pregnancy; Randomized Controlled Trials as Topic; World Health Organization; Young Adult

2015
Clarification of contraceptive drug pharmacokinetics in obesity.
    Contraception, 2017, Volume: 95, Issue:1

    Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity

2017
Progestin-only contraceptives: effects on weight.
    The Cochrane database of systematic reviews, 2016, Aug-28, Issue:8

    Topics: Adolescent; Adult; Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Retrospective Studies; Weight Gain

2016
Progestin-only contraceptives: effects on weight.
    The Cochrane database of systematic reviews, 2011, Apr-13, Issue:4

    Topics: Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain

2011
NORPLANT: levonorgestrel-releasing contraceptive implant.
    Annals of medicine, 1993, Volume: 25, Issue:2

    Topics: Body Weight; Drug Implants; Female; Forearm; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Pregnancy

1993

Trials

36 trial(s) available for levonorgestrel and Body Weight

ArticleYear
Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception.
    Contraception, 2015, Volume: 91, Issue:2

    Topics: Body Mass Index; Body Weight; Contraceptives, Postcoital; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Ireland; Levonorgestrel; Models, Biological; Overweight; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Risk; United Kingdom; United States

2015
A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
    European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 150, Issue:1

    Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Iran; Levonorgestrel; Metrorrhagia; Nausea; Patient Satisfaction

2010
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.
    Contraception, 2012, Volume: 85, Issue:3

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult

2012
Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:8

    Topics: Administration, Cutaneous; Adolescent; Adult; Body Weight; Coitus; Contraception; Contraceptive Agents, Male; Drug Implants; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Male; Middle Aged; Sex Hormone-Binding Globulin; Spermatogenesis; Testis; Testosterone

2002
Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:11

    Topics: Adipose Tissue; Adolescent; Adult; Alkaline Phosphatase; Anorexia Nervosa; Body Composition; Body Image; Body Weight; Bone Density; Collagen; Collagen Type I; Dehydroepiandrosterone; Energy Intake; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Nutritional Physiological Phenomena; Osteocalcin; Osteoporosis; Peptides

2002
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Contraception, 2002, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage

2002
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
    Contraception, 2004, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand

2004
Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 microg plus levonorgestrel 100 microg.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007, Volume: 23, Issue:11

    Topics: Blood Glucose; Body Composition; Body Weight; Electric Impedance; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids

2007
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
    Contraception, 1982, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides

1982
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
    Contraception, 1984, Volume: 30, Issue:6

    Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand

1984
Clinical experience with a low-dose contraceptive agent. European studies.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism

1983
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
    Contraception, 1983, Volume: 27, Issue:1

    Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors

1983
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
    Contraception, 1981, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina

1981
Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
    Contraception, 1982, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Random Allocation

1982
Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    American journal of obstetrics and gynecology, 1995, Volume: 172, Issue:1 Pt 1

    Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Female; Headache; Humans; Levonorgestrel; Postpartum Period; Prospective Studies; Uterine Hemorrhage

1995
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception, 1994, Volume: 50, Issue:1

    Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand

1994
Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
    Contraception, 1994, Volume: 50, Issue:2

    Topics: Adult; Body Mass Index; Body Weight; Coitus; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Prospective Studies

1994
Blood pressure changes and hormonal contraceptives.
    Contraception, 1994, Volume: 50, Issue:2

    Topics: Adult; Blood Pressure; Body Weight; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Progestins; Prospective Studies; Regression Analysis

1994
Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
    Contraception, 1993, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Body Weight; Drug Implants; Family Characteristics; Female; Follow-Up Studies; Foreign-Body Migration; Humans; Infections; Levonorgestrel; Menstruation Disturbances; Patient Dropouts; Patient Satisfaction; Pregnancy

1993
Effectiveness of Norplant implants through seven years: a large-scale study in China.
    Contraception, 1995, Volume: 52, Issue:2

    Topics: Adult; Age Factors; Body Weight; China; Cohort Studies; Drug Implants; Female; Humans; Levonorgestrel; Life Tables; Pregnancy; Pregnancy Rate; Time Factors

1995
Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
    Contraception, 1997, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Time Factors

1997
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Contraception, 1999, Volume: 60, Issue:1

    Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds

1999
Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
    European journal of medical research, 2000, Feb-28, Volume: 5, Issue:2

    Topics: Administration, Cutaneous; Body Mass Index; Body Weight; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Leptin; Levonorgestrel; Middle Aged; Obesity; Postmenopause

2000
Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.
    Contraception, 2000, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Proportional Hazards Models; Sterilization, Tubal; Time Factors

2000
A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.
    Fertility and sterility, 2001, Volume: 76, Issue:3

    Topics: Acne Vulgaris; Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Placebos; Surveys and Questionnaires

2001
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
    Contraception, 2001, Volume: 63, Issue:6

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy

2001
Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
    Methods and findings in experimental and clinical pharmacology, 2001, Volume: 23, Issue:4

    Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Climacteric; Drug Combinations; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Lipids; Middle Aged; Postmenopause; Triglycerides

2001
The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Sep-29, Volume: 56, Issue:14

    Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Time Factors; Triglycerides

1979
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1992, Volume: 156

    Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel

1992
Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone.
    Contraception, 1991, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Blood Pressure; Body Weight; Factor X; Female; Glucose; Glucose Tolerance Test; Hemoglobins; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Norethindrone; Patient Acceptance of Health Care; Risk Factors

1991
Effects of various IUDs on the composition of cervical mucus.
    Contraception, 1991, Volume: 43, Issue:5

    Topics: Body Weight; Cervix Uteri; Cholesterol; Estradiol; Female; Humans; Immunoglobulin G; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mucins; Mucus; Progesterone; Serum Albumin

1991
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
    Contraception, 1990, Volume: 41, Issue:2

    Topics: Administration, Intravaginal; Body Weight; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pregnancy

1990
A comparative analysis of three different dose combinations of oral contraceptives.
    Contraception, 1989, Volume: 39, Issue:2

    Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy

1989
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
    Human nutrition. Clinical nutrition, 1986, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins

1986
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Contraception, 1987, Volume: 36, Issue:2

    Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Random Allocation

1987
Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
    Contraception, 1985, Volume: 32, Issue:6

    Topics: Adult; Body Height; Body Weight; Breast Feeding; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Intrauterine Devices; Lactation; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism

1985

Other Studies

48 other study(ies) available for levonorgestrel and Body Weight

ArticleYear
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
    Journal of basic and clinical physiology and pharmacology, 2019, Aug-30, Volume: 30, Issue:5

    Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats

2019
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2020, Volume: 25, Issue:6

    Topics: Body Weight; Contraceptive Agents, Hormonal; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel

2020
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
    Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:6

    Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides

2018
"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online.
    Women & health, 2020, Volume: 60, Issue:3

    Topics: Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Labeling; Female; Humans; Levonorgestrel; Norpregnadienes; Obesity; Pharmaceutical Services, Online; United States

2020
A tale of two label changes.
    Contraception, 2014, Volume: 90, Issue:1

    Topics: Body Weight; Contraception, Postcoital; European Union; Female; Humans; Levonorgestrel; Patient Education as Topic; Product Labeling; United States

2014
Weight and body mass index among female contraceptive clients.
    Contraception, 2015, Volume: 91, Issue:6

    Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Cross-Sectional Studies; Female; Humans; Levonorgestrel; Obesity; Prevalence; United States; Young Adult

2015
Rethink weight limits on morning-after pill.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Jul-14, Volume: 187, Issue:10

    Topics: Body Mass Index; Body Weight; Canada; Contraceptives, Postcoital; Female; Guideline Adherence; Humans; Levonorgestrel; Pharmacists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome

2015
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Contraception, 2015, Volume: 92, Issue:6

    Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult

2015
Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
    Gynecologic oncology, 2016, Volume: 140, Issue:2

    Topics: Adult; Body Weight; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Young Adult

2016
Changes in body composition in women using long-acting reversible contraception.
    Contraception, 2017, Volume: 95, Issue:4

    Topics: Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Linear Models; Prospective Studies; Young Adult

2017
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:2

    Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity

2011
Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Contraception, 2012, Volume: 86, Issue:4

    Topics: Abdominal Fat; Absorptiometry, Photon; Adiposity; Adolescent; Adult; Body Composition; Body Mass Index; Body Weight; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Prospective Studies; Weight Gain; Young Adult

2012
Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres.
    Human reproduction (Oxford, England), 2012, Volume: 27, Issue:7

    Topics: Absorbable Implants; Animals; Biocompatible Materials; Body Weight; Disease Models, Animal; Endometriosis; Female; Humans; Levonorgestrel; Microspheres; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Treatment Outcome

2012
Menstrual changes during Norplant use and return of fertility following Norplant implant removal: the Singapore experience.
    Advances in contraceptive delivery systems : CDS, 1991, Volume: 7, Issue:2

    Topics: Asia; Asia, Southeastern; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Follow-Up Studies; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Physiology; Research; Singapore

1991
Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Advances in contraceptive delivery systems : CDS, 1992, Volume: 8, Issue:1-2

    Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms

1992
Prospective experience with a levonorgestrel implant--Norplant.
    Contraceptive delivery systems, 1984, Volume: 5, Issue:4

    Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic

1984
Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Acta therapeutica, 1990, Volume: 16, Issue:2

    Topics: Belgium; Biology; Blood; Blood Pressure; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Data Collection; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; Incidence; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Research Design

1990
Oral contraception and cyclic changes in premenstrual and menstrual experiences.
    Journal of psychosomatic obstetrics and gynaecology, 2003, Volume: 24, Issue:3

    Topics: Abdominal Pain; Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome; Prospective Studies

2003
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
    African journal of reproductive health, 2005, Volume: 9, Issue:2

    Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss

2005
Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
    Nigerian journal of clinical practice, 2007, Volume: 10, Issue:2

    Topics: Adult; Amenorrhea; Body Weight; Contraceptive Agents, Female; Female; Hematocrit; Humans; Levonorgestrel; Menstruation; Nigeria; Prospective Studies

2007
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism

1983
A new ultra-low-dose combination oral contraceptive.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl

    Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Stereoisomerism

1983
Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
    Contraception, 1983, Volume: 27, Issue:1

    Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors

1983
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Current medical research and opinion, 1983, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage

1983
Long term toxicological studies on the progestin STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors

1983
Data on acute toxicity of the progestin STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity

1983
Low dosage oral contraception in women with previous gestational diabetes.
    Obstetrics and gynecology, 1982, Volume: 59, Issue:3

    Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prospective Studies

1982
A cohort study of Norplant implant: side-effects and acceptance.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1995, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage

1995
Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Contraception, 1995, Volume: 51, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Apolipoprotein A-I; Bilirubin; Body Weight; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Progestins; Sex Hormone-Binding Globulin; Time Factors; Triglycerides; United States

1995
Adolescents and Norplant: preliminary findings of side effects.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 1995, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Analysis of Variance; Arkansas; Black or African American; Blood Pressure; Body Weight; Chi-Square Distribution; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Retrospective Studies; Time Factors; White People

1995
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
    American journal of obstetrics and gynecology, 1995, Volume: 172, Issue:4 Pt 1

    Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis

1995
Use of Norplant in Pakistan: two years experience.
    JPMA. The Journal of the Pakistan Medical Association, 1994, Volume: 44, Issue:1

    Topics: Adult; Body Weight; Drug Implants; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Pakistan; Socioeconomic Factors

1994
Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.
    Contraception, 1995, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Africa; Asia; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Latin America; Levonorgestrel; Life Tables; Menstruation; Pregnancy; Pregnancy Rate

1995
Risk factors for discontinuation of Norplant implant use due to menstrual problems.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1996, Volume: 12, Issue:3

    Topics: Adult; Body Weight; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Pregnancy; Risk Factors; Smoking

1996
Efficacy and continuation rates of Norplant in Pakistan.
    Contraception, 1999, Volume: 60, Issue:1

    Topics: Adult; Age Factors; Body Weight; Contraceptive Agents, Female; Educational Status; Employment; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Pakistan; Parity; Patient Satisfaction; Pregnancy; Pregnancy Rate

1999
A 10-year follow-up study of contraceptive Norplant implants.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2000, Volume: 68, Issue:3

    Topics: Adult; Body Weight; Contraceptive Agents, Female; Device Removal; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances

2000
Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants.
    Contraception, 2001, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Blood Specimen Collection; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Regression Analysis; Time Factors

2001
The effect of low-dose oral contraceptives and Norplant on blood pressure and body weight of Nigerian women.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1992, Volume: 8, Issue:1

    Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Implants; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Nigeria; Norgestrel; Prospective Studies

1992
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
    The Journal of clinical investigation, 1991, Volume: 87, Issue:4

    Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Endometrium; Energy Intake; Estradiol; Estradiol Dehydrogenases; Female; Isocitrate Dehydrogenase; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Ovariectomy; Rabbits

1991
Effects of oral contraceptive pills on serum lipoproteins and triglycerides.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1990, Volume: 33, Issue:3

    Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Regression Analysis; Time Factors; Triglycerides

1990
Norplant contraceptive subdermal implants: two-year experience in Singapore.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1989, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Singapore

1989
Norplant-2 rods contraceptive subdermal implants: two-year experience in Singapore.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1989, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Silicone Elastomers; Singapore

1989
Five-year experience with Norplant implants in Assiut, Egypt.
    Contraception, 1987, Volume: 35, Issue:6

    Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage

1987
[Evaluation of the contraceptive agent norplant in the municipality of Rio de Janeiro, RJ (Brazil)].
    Revista de saude publica, 1987, Volume: 21, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Blood Pressure; Body Weight; Evaluation Studies as Topic; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Norgestrel; Parity; Product Surveillance, Postmarketing

1987
Effect of food-restriction on steady state kinetics and tissue distribution of norethindrone and levonorgestrel in rabbits.
    Indian journal of experimental biology, 1988, Volume: 26, Issue:5

    Topics: Animals; Body Weight; Female; Food Deprivation; Levonorgestrel; Metabolic Clearance Rate; Norethindrone; Norgestrel; Organ Size; Rabbits; Tissue Distribution

1988
Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants.
    Contraception, 1988, Volume: 38, Issue:5

    Topics: Adult; Body Composition; Body Weight; Delayed-Action Preparations; Female; Half-Life; Humans; Levonorgestrel; Norgestrel

1988
Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India.
    Contraception, 1988, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy

1988
[Influence of Norplant contraceptive implants on lactation and infant growth].
    Revista chilena de obstetricia y ginecologia, 1985, Volume: 50, Issue:5

    Topics: Body Weight; Breast Feeding; Female; Growth; Humans; Infant; Infant, Newborn; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Male; Milk, Human; Norgestrel; Pregnancy

1985